Q1 2026 ONWARD Medical NV Earnings Call Transcript
Key Points
- Onward Medical NV (ONWRF) achieved EUR2 million in revenue in Q1 2026, with ARC-EX systems now available in over 100 clinics across the US and Europe.
- The company successfully raised over EUR40 million in new equity capital, extending its cash runway into Q1 2028.
- Onward Medical NV (ONWRF) has made significant progress in its Empower BP pivotal trial for ARC-IM, with the first participant enrolled and implanted and 12 sites activated.
- The company has expanded the availability of ARC-EX technology for home use, particularly focusing on the US Department of Veterans Affairs.
- Onward Medical NV (ONWRF) has initiated new feasibility studies, including the IGR mobility study and the EIGER feasibility study, to further advance its pipeline.
- The company did not provide specific numbers on the split of units placed between the US and Europe or between clinic and home use.
- Grant income, which contributed EUR0.7 million to revenue, is expected to be lumpy and not a consistent source of income.
- The VA's purchasing process involves a two-month evaluation period, which could delay revenue recognition from these units.
- Onward Medical NV (ONWRF) is facing challenges in the MedTech sector, with its stock price down over the past six months.
- The company is not providing detailed guidance on future sales or specific numbers of units sold in various categories, which may limit transparency for investors.
Good day, and thank you for standing by. Welcome to the Onward Medical Q1 2026 results webcast and conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to our first speaker today, Sébastien Cros, VP of Communications. Please go ahead.
Thank you, Sharon. Good morning, good afternoon, everyone, welcome to Onward's webcast following the publication of our results for Q1 earlier today.
Before we get started, as usual, please take a moment to read our disclaimer. This presentation includes forward-looking statements, which should be considered with the appropriate level of caution as outlined on this page. This deck and the recording of the webcast will be made available after our call.
Today, I'm joined with three members of Onward leadership team, Dave, our CEO; Sean Sciara, our Chief Commercial Officer; and Ali Kiboro, Chief Financial Officer.
As always, we will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
